Ublituximab Biosimilar – Anti-MS4A1, CD20 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameUblituximab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade
SourceCAS 1174014-05-1
SpeciesChimeric
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsUblituximab,LFB-R603, TG-1101,TGTX-1101,MS4A1, CD20,anti-MS4A1, CD20
ReferencePX-TA1264
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Ublituximab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade

General information on Anti-MS4A1/CD20[Homo sapiens] (Ublituximab) Monoclonal Antibody

Ublituximab has been investigated for the treatment of B-cell Lymphoma, Neuromyelitis Optica, Mantle Cell Lymphoma, Non-Hodgkins Lymphoma, and Marginal Zone Lymphoma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Ublituximab Biosimilar – Anti-MS4A1, CD20 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD20 Protein – Human CD20 Recombinant Protein
Antigen

CD20 Protein – Human CD20 Recombinant Protein

PX-P3060 210€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products